Work

Characterization of clinical pharmacokinetics and exposure-response relationships of AMG 330, a bispecific CD33 T-cell engager antibody construct, in patients with relapsed/refractory AML.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.7536

Authors: Suresh K Agarwal, Sharvari Bhagwat, Khamir Mehta, Antreas Hindoyan, Anthony Selwyn Stein, Farhad Ravandi, Marion Subklewe, Roland B. Walter, Mojca Jongen-Lavrencic, Gert J. Ossenkoppele, Peter Paschka, Sophia Khaldoyanidi, Sandeep Dutta, Vijay V. Upreti

Institutions: Amgen (United States), City Of Hope National Medical Center, City of Hope, The University of Texas MD Anderson Cancer Center, LMU Klinikum, Ludwig-Maximilians-Universität München, Fred Hutch Cancer Center, Erasmus MC, Amsterdam UMC Location Vrije Universiteit Amsterdam, Universität Ulm, University Hospital Ulm

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Amgen

OpenAlex ID: W3030940837

Cites:

Cited by: 3

Related to: 10